Trending
November 5, 2024

AdaptHealth Corp. Announces Third Quarter 2024 Results

November 4, 2024

Cornucopian Capital Joins $20M Round for Archon Biosciences

November 4, 2024

CarePoint Initiates Financial Restructuring

October 31, 2024

Harmony Biosciences Holdings Prices of Public Offering of Common Stock

October 31, 2024

Insmed Reports Third-Quarter 2024 Financial Results and Provides Business Update

October 31, 2024

Bristol Myers Squibb Reports Third Quarter Financial Results for 2024

October 31, 2024

Merck Announces Third-Quarter 2024 Financial Results

October 30, 2024

Orthobond Appoints George Landau as EVP, Business Development and Commercialization

October 30, 2024

Northpond Ventures-Backed Transition Bio Raises $13.3M

October 29, 2024

Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs

October 29, 2024

Pfizer Reports Strong Third-Quarter 2024 Results And Raises 2024 Guidance

October 25, 2024

BD Named Among the 100 Best Corporate Citizens of 2024

October 24, 2024

Insmed Ranks No. 1 on Science’s 2024 Top Biopharma Employers List

October 24, 2024

HR HealthCare Appoints Dallas Donald as VP and Melissa Georgeoff as Chief Contracting Officer

October 24, 2024

Avalon GloboCare Announces 1-for-15 Reverse Stock Split

October 23, 2024

Interview with Adam Low, CEO of SENTA Partners